Search results for: 'diseas intelligent pharma'

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

This study examines the prevailing trends in the intelligent mobility market in Australia for 2016–2025. It offers a detailed overview of the key segments in the market. The study focuses on various developments in these segments including their current and future revenue analysis. The study contains an executive summary section, as well as one for...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

This research service presents an analysis of selected infectious disease IVD in the APAC market. The study is segmented based on the following three main methods of diagnostic technologies used: microbiology testing, immunochemistry, and molecular diagnostics. It provides in-depth analysis of infectious diseases with higher occurrence in the Asia-...

This research study focuses on providing all the presentations from Frost & Sullivan's two-day workshop event held in September 2019 in Tokyo, called Intelligent Mobility. These include presentations from Frost & Sullivan Indian team and a host of other companies such as Amazon Web Services, Connector, DHL, Murata Manufacturing Co, Navitime Japan, ...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

World Health Organization statistics state that by 2030, one out of six people will be 60 years of age or more. The aged population will likely increase from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion by 2050. The senior population typically experiences a gradual decrease in physical and mental capacity. This causes a high disease and...

This research service analyzes the intelligent automation (IA) market in Asia-Pacific (APAC). It presents an overview on how artificial intelligence (AI) and robotic process automation (RPA) are gaining significance across key countries in the region, their applications, and some of the drivers and restraints in using these technologies. This stu...